The Immunological Effect of Il-17 and Il-6 on the Development of Autoimmune Disease: Systemic Lupus Erythematosus in Iraqi Patients

Background: Alterations in immune system balance and the production of autoantibodies that attack features inside cells are important hallmarks of systemic lupus erythematosus (SLE), a chronic autoimmune disease. SLE is a challenging form of things that range from immune system foul-ups, exterior forces, hormone influences and even genes that just make it more likely. B and T cells, along with antigen-presenting cells, drive much of that inflammation-making material, primarily IL-6 and IL-17. Both natural and acquired body guards get much to wound up in the sickness, Objective: Interleukin-6 and interleukin-17 contributes to systemic lupus erythematosus (SLE) pathogenesis and may serve as biomarkers of disease-associated inflammation. This study evaluated these cytokines and other inflammatory markers in patients with SLE and healthy controls. Methodology: The study included ninety individuals of both sexes, ranging in age from thirteen to seventy years. They were divided into two main groups: 40 (29 females and 11 males) were assigned as controls and 51 (39 females and 12 males) were assigned as SLE patients. The diagnosis of SLE was established through patient interviews and physical examination. A venipuncture was performed for blood collection, and three tubes were utilized for ESR measurement. Serum was obtained and centrifuged for CRP and RF assays. Cellular cytokines such as interleukin-6 and interleukin-17 were determined by ELISA. Results: The levels of IL-6 and IL-17 were significantly higher in SLE patients than those in healthy subjects. It shows that these things are very much related to how unwell and how active the disease Levels of Erythrocyte Sedimentation Rate) ESR (, C-Reactive Protein)CRP(Rheumatoid Factor)RF( in patients, and ANA all significantly enhanced. Results indicate that IL-17, mainly produced by Th17 cells, recruits’ neutrophils and induces more inflammatory cytokines increasing tissue damage, while IL-6 stimulates maturation of B-cells and production of autoantibodies. In addition, the current study confirmed that Systemic lupus erythematosus is more frequent in women. Conclusion: Elevated levels of IL-6 and IL-17 may be linked to inflammation associated with SLE and may serve as future therapeutic targets as well as diagnostic biomarkers. Additional research is required to determine their therapeutic potential and diagnostic utility.

Authors

Institutions

Publication Details

Journal
Journal of Biotechnology Research Center
Published
2026-11-17
DOI
https://doi.org/10.24126/jobrc.2026.20.2.961
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Immunological Effect of Il-17 and Il-6 on the Development of Autoimmune Disease: Systemic Lupus Erythematosus in Iraqi Patients

Marwah Sabah Altaiee, Hayam Aziz Mohammed, Muhannad Illayan Massadeh, Teeba Fares Hadi et al.
Journal of Biotechnology Research Center
Systemic Lupus Erythematosus Research
article

The Immunological Effect of Il-17 and Il-6 on the Development of Autoimmune Disease: Systemic Lupus Erythematosus in Iraqi Patients

Marwah Sabah Altaiee, Hayam Aziz Mohammed, Muhannad Illayan Massadeh, Teeba Fares Hadi, Batol I. Dheeb
article en

Abstract

Background: Alterations in immune system balance and the production of autoantibodies that attack features inside cells are important hallmarks of systemic lupus erythematosus (SLE), a chronic autoimmune disease. SLE is a challenging form of things that range from immune system foul-ups, exterior forces, hormone influences and even genes that just make it more likely. B and T cells, along with antigen-presenting cells, drive much of that inflammation-making material, primarily IL-6 and IL-17. Both natural and acquired body guards get much to wound up in the sickness, Objective: Interleukin-6 and interleukin-17 contributes to systemic lupus erythematosus (SLE) pathogenesis and may serve as biomarkers of disease-associated inflammation. This study evaluated these cytokines and other inflammatory markers in patients with SLE and healthy controls. Methodology: The study included ninety individuals of both sexes, ranging in age from thirteen to seventy years. They were divided into two main groups: 40 (29 females and 11 males) were assigned as controls and 51 (39 females and 12 males) were assigned as SLE patients. The diagnosis of SLE was established through patient interviews and physical examination. A venipuncture was performed for blood collection, and three tubes were utilized for ESR measurement. Serum was obtained and centrifuged for CRP and RF assays. Cellular cytokines such as interleukin-6 and interleukin-17 were determined by ELISA. Results: The levels of IL-6 and IL-17 were significantly higher in SLE patients than those in healthy subjects. It shows that these things are very much related to how unwell and how active the disease Levels of Erythrocyte Sedimentation Rate) ESR (, C-Reactive Protein)CRP(Rheumatoid Factor)RF( in patients, and ANA all significantly enhanced. Results indicate that IL-17, mainly produced by Th17 cells, recruits’ neutrophils and induces more inflammatory cytokines increasing tissue damage, while IL-6 stimulates maturation of B-cells and production of autoantibodies. In addition, the current study confirmed that Systemic lupus erythematosus is more frequent in women. Conclusion: Elevated levels of IL-6 and IL-17 may be linked to inflammation associated with SLE and may serve as future therapeutic targets as well as diagnostic biomarkers. Additional research is required to determine their therapeutic potential and diagnostic utility.

Journal of Biotechnology Research CenterVol. 20(2)
University of Baghdad (IQ), Hashemite University (JO), University of Samarra (IQ)
Good health and well-being
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon